Recent News

Rethink testing. New research shows how to reduce COVID-19 quarantine times by almost half simply by testing on exit from quarantine instead of entry.

A molecular biologist cultures an ecological perspective of biothreats in his new role at the Emerging Pathogens Institute.

A warming world will shift arboviruses, such as Zika virus, into new areas where human populations are susceptible to infection.

UF plant pathologists affiliated with both IFAS and the EPI earned the distinction of having a “top-viewed” poster at the virtual annual meeting of the American Phytopathological Society.

A lack of coordination in measures to control COVID-19 may accelerate cyclical outbreaks, according to a team of UF researchers.

UF researchers ask how knowledge, attitudes and behaviors regarding the COVID-19 pandemic may affect infection rates, and the mental health, of children and their parents.

Infectious disease modeler and biostatistician Ira Longini is applying decades of experience to help design and analyze clinical trials to identify a safe and effective COVID-19 vaccine.

UF infectious disease researcher Rhoel Dinglasan was part of a team that devised a saliva-based test for COVID-19. The team's design was one of six winners of the first-ever National Institutes of Health Technology Accelerator Challenge competition.

UF researchers sifted through several thousand studies on human coronaviruses related to the novel SARS-CoV-2 which causes COVID-19, with the goal of learning from the past to help shape the future.

UF researchers Chang-Yu Wu, an engineer, and John Lednicky, a virologist, teamed up a decade ago to solve long-standing challenges in how air samples are collected and tested for viruses. Few people grasped the public health value of their work until a novel respiratory virus gave rise to the COVID-19 pandemic.